✦ LIBER ✦

34 Phase 2 study of neoadjuvant docetaxel and androgen suppression (AS) Plus Radiation Therapy (RT) for high risk localized prostate cancer (HRLCaP)

✍ Scribed by M. McKenzie; K. Chi; A. Neville; S. Ellard; B. Baerg; D. Ruether; E. Winquist; R. Segal; A. Attwell; H. Lukka

Book ID: 119517825
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 258 KB
Volume: 80
Category: Article
ISSN: 0167-8140
DOI: 10.1016/s0167-8140(06)80775-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Radiation Therapy Oncology Group 0521: A

Radiation Therapy Oncology Group 0521: A Phase III Randomized Trial of Androgen Suppression and Radiation Therapy Versus Androgen Suppression and Radiation Therapy Followed by Docetaxel/Prednisone for Localized, High-Risk Prostate Cancer

✍ Asmita R. Patel; Howard M. Sandler; Kenneth J. Pienta 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 873 KB

Phase 2 study of neoadjuvant docetaxel p

Phase 2 study of neoadjuvant docetaxel plus bevacizumab in patients with high-risk localized prostate cancer : A Prostate Cancer Clinical Trials Consortium trial

✍ Robert W. Ross; Matthew D. Galsky; Phil Febbo; Marc Barry; Jerome P. Richie; Wan 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 253 KB

Sunitinib Plus Androgen Deprivation and

Sunitinib Plus Androgen Deprivation and Radiation Therapy for Patients With Localized High-Risk Prostate Cancer: Results From a Multi-institutional Phase 1 Study

✍ Corn, Paul G.; Song, Danny Y.; Heath, Elisabeth; Maier, Jordan; Meyn, Raymond; K 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 191 KB

Multicenter Phase II Study of Combined N

Multicenter Phase II Study of Combined Neoadjuvant Docetaxel and Hormone Therapy Before Radical Prostatectomy for Patients With High Risk Localized Prostate Cancer

✍ Chi, Kim N.; Chin, Joseph L.; Winquist, Eric; Klotz, Laurence; Saad, Fred; Gleav 📂 Article 📅 2008 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 131 KB

Phase I study of concurrent weekly docet

Phase I study of concurrent weekly docetaxel, high-dose intensity-modulated radiation therapy (IMRT) and androgen-deprivation therapy (ADT) for high-risk prostate cancer

✍ Ronald C. Chen; Julian G. Rosenman; Leroy G. Hoffman; Wing-Keung Chiu; Andrew Z. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 211 KB

Re: Multicenter Phase II Study of Combin

Re: Multicenter Phase II Study of Combined Neoadjuvant Docetaxel and Hormone Therapy before Radical Prostatectomy for Patients with High Risk Localized Prostate Cancer

✍ P. Beuzeboc 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 94 KB